Medicine:Alwadei Syndrome
| Alwadei Syndrome | |
|---|---|
| Other names | Autosomal recessive mental retardation-61, Mental retardation, autosomal recessive 61, MRT61 |
 | |
| Alwadei Syndrome has an autosomal recessive pattern of inheritance | |
| Specialty | Neurology |
| Symptoms | dysmorphic facial features, intellectual disability, delayed psychomotor development, neurological malformations,seizures |
| Usual onset | Infancy |
Alwadei Syndrome or Autosomal recessive mental retardation-61 (MRT61) is an autosomal recessive neurodevelopmental disorder characterized by delayed psychomotor development, intellectual disability, and variable abnormal facial features.[1] [2][3] Severe patients may develop refractory seizures and have brain abnormalities, including hypoplasia of the corpus callosum.[3] Alwadei Syndrome attributed to mutation in RUSC2 gene on chromosome 9p13.3.[2]
Signs and Symptoms
Patients with Alwadei Syndrome typically have moderate to severe intellectual disability. Speech is delayed and once acquired is limited to single words. Behavioral problems such as hyperactivity, aggression and autistic features can occur. As of 2017 three patients with Alwadei syndrome have been reported, all of whom have been dependent on assistance in all aspects of daily living.[4]
Hypotonia occurs in infancy and in most cases later progresses to mild spasticity in all four limbs. Walking is delayed and in all cases is unsteady. Joint hyperlaxity may occur.[citation needed]
Diagnosis
History
It was first described at King Fahd Medical City by the pediatric neurologist Ali Alwadei in 2014. The syndrome was recognized and published in medical journal Developmental Medicine & Child Neurology in 2016.[3] In 2017, Johns Hopkins University named the syndrome as "Alwadei Syndrome".[citation needed]
References
- ↑ Rasika, Sowmyalakshmi; Passemard, Sandrine; Verloes, Alain; Gressens, Pierre; El Ghouzzi, Vincent (26 December 2019). "Golgipathies in Neurodevelopment: A New View of Old Defects". Developmental Neuroscience 40 (5–6): 396–416. doi:10.1159/000497035. PMID 30878996. https://hal.archives-ouvertes.fr/hal-02322665/file/Rasika%2C%20Golgipathies%20in%20Neurodevelopment%20Final%20Manuscript_27Nov2018.pdf.
- ↑ 2.0 2.1 "MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61". omim.org. https://omim.org/entry/617773. Retrieved 26 December 2019.
- ↑ 3.0 3.1 3.2 Alwadei, Ali H.; Benini, Ruba; Mahmoud, Adel; Alasmari, Ali; Kamsteeg, Erik-Jan; Alfadhel, Majid (1 December 2016). "Loss-of-function mutation in RUSC2 causes intellectual disability and secondary microcephaly". Developmental Medicine and Child Neurology 58 (12): 1317–1322. doi:10.1111/dmcn.13250. PMID 27612186.
- ↑ "MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61;". omim.org. https://omim.org/entry/617773.
| Classification |
|---|
 |
